ResMed

Health Care Health Care Equipment San Diego, California Last filing Aug 8, 2025 · FY2025

                    Revenue
                    FY2025
                
$5.1B
                    3y CAGR +12.9%
                    
                    P88
                    
                    +9.8%
                    
                    Net income
                    FY2025
                
$1.4B
                    Net margin +27.2%
                    
                    P87
                    
                    +37.2%
                    
                    Total assets
                    FY2025
                
$8.2B
                    ROA +17.1%
                    
                    P92
                    
                    +18.9%
                    
                    Operating cash flow
                    FY2025
                
$1.8B
                    FCF margin +32.3%
                    
                    P100
                    
                    +25.0%

19 yrs · FY1997–FY2025 10 gaps (2001–1998, 2008–2003) 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

33 accounts · 10 years

Total assets $8.2B

Total liabilities $2.2B

Shareholders equity $6.0B

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Assets
Cash and Cash Equivalents	23.5%	5.1%	5.4%	7.6%	9.2%	15.7%	5.6%	8.1%	39.8%	39.8%
Accounts Receivable	18.3%	17.9%	16.7%	16.1%	19.2%	16.1%	20.3%	20.7%	21.8%	20.8%
Inventory	18.0%	—	—	—	—	—	—	—	—	—
Prepaid Expenses	8.3%	—	—	—	—	—	—	—	—	—
Other Current Assets	3.2%	—	—	—	—	—	—	—	—	—
Total Current Assets	68.1%	50.3%	56.1%	54.0%	49.3%	51.5%	43.9%	45.5%	79.5%	77.2%
Property,Plant and Equipment	10.7%	11.7%	12.7%	13.9%	14.5%	14.1%	14.9%	16.5%	19.1%	20.9%
Operating Lease Assets	3.3%	3.2%	3.0%	3.7%	4.0%	4.0%	—	—	—	—
Goodwill	59.2%	60.7%	65.6%	54.1%	60.3%	63.9%	71.2%	45.7%	51.5%	57.6%
Intangible Assets	9.0%	—	—	—	—	—	—	—	—	—
Long Term Investments	1.5%	1.4%	1.5%	0.3%	0.5%	0.5%	0.8%	0.0%	1.9%	—
Other Noncurrent Assets	3.6%	6.1%	6.2%	4.8%	5.0%	5.0%	5.8%	11.7%	2.0%	2.1%
Total Assets	158.8%	146.7%	159.9%	142.4%	147.9%	155.1%	157.6%	130.9%	167.8%	177.1%
Liabilities
Accounts Payable	5.4%	5.1%	3.6%	4.5%	4.3%	4.6%	4.4%	4.0%	4.5%	5.0%
Accrued Liabilities	7.8%	8.1%	8.7%	9.6%	10.0%	9.1%	10.2%	7.9%	9.0%	8.5%
Deferred Revenue	3.2%	—	—	—	—	—	—	—	—	—
Current Portion of Long Term Debt	0.2%	—	—	—	—	—	—	—	—	—
Operating Lease Liabilities	0.6%	—	—	—	—	—	—	—	—	—
Other Current Liabilities	0.0%	0.7%	0.7%	0.7%	0.7%	0.7%	0.8%	0.8%	0.9%	0.8%
Total Current Liabilities	19.8%	19.4%	18.0%	19.3%	28.5%	20.4%	21.3%	21.8%	17.4%	34.7%
Long Term Debt	12.8%	14.9%	33.9%	21.4%	20.1%	39.4%	48.3%	11.5%	52.2%	47.5%
Deferred Revenue Noncurrent	3.0%	—	—	—	—	—	—	—	—	—
Operating Lease Liabilities Noncurrent	3.0%	3.0%	2.8%	3.4%	3.6%	3.4%	—	—	—	—
Other Noncurrent Liabilities	2.7%	0.9%	1.6%	0.2%	0.2%	0.3%	0.1%	0.0%	0.1%	0.1%
Total Liabilities	42.9%	42.9%	62.1%	48.5%	57.6%	70.7%	78.1%	42.9%	73.0%	84.9%
Equity
Preferred Stock	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.1%	0.1%
Common Stock	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Additional Paid In Capital	39.5%	40.5%	42.0%	47.0%	50.7%	53.1%	58.0%	62.0%	66.7%	70.9%
Retained Earnings	118.2%	—	—	—	—	—	—	—	—	—
Treasury Stock	40.3%	—	—	—	50.8%	54.9%	62.3%	68.4%	74.8%	84.1%
Accumulated Other Comprehensive Income	-1.5%	—	—	—	—	—	—	—	—	—
Total Stockholders Equity	116.0%	103.8%	97.8%	93.9%	90.3%	84.4%	79.5%	88.0%	94.9%	92.2%
Total Liabilitiesand Equity	158.8%	146.7%	159.9%	142.4%	147.9%	155.1%	157.6%	130.9%	167.8%	177.1%

Income Statement

Revenue, expense, and profitability

19 accounts · 10 years

Revenue $5.1B

Operating income $1.7B

Net income $1.4B

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
IncomeStatement
Revenues Total Revenue	100.0%	—	—	—	—	—	—	—	—	—
Expenses Cost of Revenue	40.6%	—	—	—	—	—	—	—	—	—
Expenses Research and Development	6.4%	—	—	—	—	—	—	—	—	—
Expenses Selling,General and Administrative	19.3%	—	—	—	—	—	—	—	—	—
Expenses Depreciation and Amortization	3.9%	—	—	—	—	—	—	—	—	—
Expenses Share Based Compensation	1.8%	—	—	—	—	—	—	—	—	—
Expenses Restructuring and Asset Impairment	0.0%	—	—	—	—	—	—	—	—	—
Expenses Operating Expenses	26.6%	—	—	—	—	—	—	—	—	—
Other Income Expense Gross Profit	59.4%	56.7%	55.8%	56.6%	57.5%	58.1%	57.3%	57.0%	58.1%	58.0%
Other Income Expense Operating Income	32.7%	—	—	—	—	—	—	—	—	—
Other Income Expense Other Income/expense	-0.1%	—	—	—	—	—	—	—	—	—
Other Income Expense Income Before Tax	32.6%	—	—	—	—	—	—	—	—	—
Income Tax Income Tax Expense	5.4%	—	—	—	—	—	—	—	—	—
net Income net Income	27.2%	—	—	—	—	—	—	—	—	—
net Income Comprehensive Income	30.7%	—	—	—	—	—	—	—	—	—
Earnings Per Share Basic Eps	0.0%	—	—	—	—	—	—	—	—	—
Earnings Per Share Diluted Eps	0.0%	—	—	—	—	—	—	—	—	—
Earnings Per Share Weighted Average Shares Basic	2.9%	—	—	—	—	—	—	—	—	—
Earnings Per Share Weighted Average Shares Diluted	2.9%	—	—	—	—	—	—	—	—	—

Cash Flow Statement

Operating, investing, and financing flows

23 accounts · 10 years

Operating cash flow $1.8B

Investing cash flow $-200.0M

Financing cash flow $-606.3M

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CashFlow
Operating Activities net Income	27.2%	21.8%	21.3%	21.8%	14.8%	21.0%	15.5%	13.5%	16.6%	19.2%
Operating Activities Depreciation and Amortization	2.2%	1.9%	2.0%	2.3%	2.5%	2.2%	2.5%	2.8%	2.3%	1.6%
Operating Activities Stock Based Compensation	1.8%	—	—	—	—	—	—	—	—	—
Operating Activities Deferred Income Taxes	-1.2%	-1.1%	-1.1%	-0.3%	-0.5%	-1.0%	-1.9%	0.3%	-0.2%	-0.1%
Operating Activities Changes In Operating Assets and Liabilities	1.4%	4.3%	12.4%	5.9%	13.1%	1.7%	4.7%	16.8%	7.7%	1.7%
Operating Activities net Cash From Operating Activities	34.0%	—	—	—	—	—	—	—	—	—
Investing Activities Capital Expenditures	1.7%	—	—	—	—	—	—	—	—	—
Investing Activities Business Acquisitions	2.7%	—	—	—	—	—	—	—	—	—
Investing Activities Purchases of Investments	0.1%	—	—	—	—	—	—	—	—	—
Investing Activities Other Investing Activities	-0.8%	0.2%	-0.4%	0.5%	-0.6%	0.5%	0.0%	0.6%	-0.2%	0.4%
Investing Activities net Cash From Investing Activities	-3.9%	—	—	—	—	—	—	—	—	—
Financing Activities Proceeds From Debt	0.0%	—	—	—	—	—	—	—	—	—
Financing Activities Repayment of Debt	0.8%	—	—	—	—	—	—	—	—	—
Financing Activities Repurchase of Common Stock	5.8%	—	—	—	—	—	—	—	—	—
Financing Activities Dividends Paid	6.0%	—	—	—	—	—	—	—	—	—
Financing Activities Proceeds From Stock Issuance	1.4%	—	—	—	—	—	—	—	—	—
Financing Activities Tax Withholding On Stock Based Compensation	0.4%	—	—	—	—	—	—	—	—	—
Financing Activities Other Financing Activities	0.0%	0.0%	0.1%	0.0%	0.1%	0.0%	0.0%	0.0%	0.6%	0.1%
Financing Activities net Cash From Financing Activities	-11.8%	—	—	—	—	—	—	—	—	—
Cash Reconciliation Effect of Exchange Rate On Cash	0.5%	—	—	—	—	—	—	—	—	—
Cash Reconciliation net Change In Cash	18.9%	—	—	—	—	—	—	—	—	—
Cash Reconciliation Cash At Beginning of Period	23.5%	—	—	—	—	—	—	—	—	—
Cash Reconciliation Cash At End of Period	23.5%	—	—	—	—	—	—	—	—	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years

Ratio	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Profitability
Gross margin	+59.4%	+56.7%	+55.8%	+56.6%	+57.5%	+58.1%	+57.3%	+57.0%	+58.1%	—
Operating margin	+32.7%	+28.2%	+26.8%	+28.0%	+28.3%	+27.4%	+22.2%	+23.2%	+20.6%	+23.3%
Net margin	+27.2%	+21.8%	+21.3%	+21.8%	+14.8%	+21.0%	+15.5%	+13.5%	+16.6%	+19.2%
FCF margin	+32.3%	+27.8%	+13.6%	+6.0%	+19.8%	+23.9%	+15.0%	+18.9%	+17.0%	+26.6%
Growth
Revenue CAGR (3y)	+12.9%	+13.6%	+12.6%	+11.1%	+11.0%	+12.7%	+12.3%	+11.7%	+9.9%	—
Returns
ROE	+23.5%	+21.0%	+21.7%	+23.2%	+16.4%	+24.9%	+19.5%	+15.3%	+17.5%	+20.8%
ROA	+17.1%	+14.9%	+13.3%	+15.3%	+10.0%	+13.6%	+9.8%	+10.3%	+9.9%	+10.8%
ROIC	+25.9%	+24.8%	+21.2%	+25.9%	+27.8%	+25.2%	+18.1%	+25.2%	+19.2%	+20.1%
Liquidity
Current ratio	3.44x	2.59x	3.12x	2.80x	1.73x	2.53x	2.06x	2.08x	4.57x	2.23x
Quick ratio	2.11x	1.18x	1.23x	1.23x	1.00x	1.56x	1.22x	1.32x	3.53x	1.75x
Leverage
D/E	0.37x	0.41x	0.63x	0.52x	0.64x	0.84x	0.98x	0.49x	0.77x	0.92x
Interest coverage	—	—	—	—	37.67x	20.05x	16.02x	19.11x	15.08x	38.28x
Efficiency
Asset turnover	0.63x	0.68x	0.63x	0.70x	0.68x	0.64x	0.63x	0.76x	0.60x	0.56x
Cash conversion cycle	+180d	+170d	+227d	+196d	+156d	+141d	+151d	+139d	+154d	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

ResMed

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history